BioLineRx Cash Flow Statement (2023-2025) | BLRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -9.49M-8.58M-11.52M-17.54M-3.89M-3.69M-3.76M-7.94M-1.97M-2.03M-1.90M
Gains from Investment Securities 3.04M7.80M3.12M-2.91M-4.44M-8.40M-0.72M-5.40M-8.31M1.90M-1.13M
Non-cash Items 4.15M9.54M5.45M18.88M-13.41M-11.81M-4.00M-5.42M-7.72M2.41M0.23M
Cash from Operations -8.02M-9.68M-9.90M4.99M-14.11M-11.33M-9.82M-8.61M-2.59M-0.18M-2.11M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.03M0.70M
Amortization 4.15M18.88M-13.41M-5.42M-7.72M
Depreciation & Amortization (CF) 0.26M0.20M0.22M0.71M0.90M0.48M0.84M1.85M0.17M0.18M0.12M
Change in Working Capital
Change in Receivables -2.47M-0.35M-0.43M1.14M1.01M1.39M0.08M
Change in Inventory -1.35M-0.60M-0.94M-0.74M0.09M0.40M-0.17M0.47M0.67M
Change in Account Payables 0.39M-0.11M2.13M3.10M-3.51M-2.12M-0.59M0.71M
Change in Accured Expenses -3.51M-2.12M-0.59M-2.51M0.03M-0.57M
Other Working Capital Changes -0.12M0.12M-0.57M13.52M-3.93M-3.55M-3.22M-2.25M1.16M-1.16M0.79M
Investing Activities
Capital Expenditures -0.03M-0.07M-0.00M-0.02M-0.03M-0.03M0.01M
Change in Intangibles -0.10M-0.06M-0.03M-0.00M
Change in Acquisitions & Divestments -5.50M-0.51M-7.88M-33.71M16.72M-37.28M-5.79M-12.31M-12.51M-4.21M
Cash from Investing Activities 6.64M11.10M4.10M-20.39M16.69M-8.64M10.18M11.16M-8.18M-3.70M3.67M
Financing Activities
Cash from Financing Activities -0.05M-0.13M3.50M11.74M-0.89M23.88M-1.22M-1.11M9.45M1.60M-0.92M
Additional items
Exchange Rate Effect -0.10M0.44M-0.76M0.19M0.05M-0.27M0.08M0.16M-0.08M0.43M0.07M
Change in Cash -1.42M1.28M-2.31M-3.66M1.68M3.90M-0.87M1.44M-1.32M-2.28M0.65M
Free Cash Flow -7.98M-9.62M-9.90M5.01M-14.08M-11.30M-9.82M-8.62M-2.59M-0.18M-2.11M
Net Cash Flow -1.42M1.28M-2.31M-3.66M1.68M3.90M-0.87M1.44M-1.32M-2.28M0.65M